In this model, changes in LVEF and WMSI emerged as the most relevant factors for MACE prediction, along with symptom-to-balloon time, body mass index, diabetes mellitus, hypertension, prior revascularization, beta-blocker therapy, and ACE inhibitor therapy (Figure 4A). This evidence concerns the gene ACE and hypertensive disorder.